ARA-290
Erythropoietin-derived peptide (cibinetide) studied in research on tissue protection and small-fiber signalling pathways.
This material is sold strictly for laboratory and research use only. Not for human consumption, veterinary, clinical, or therapeutic use.
About ARA-290
Erythropoietin-derived peptide (cibinetide) studied in research on tissue protection and small-fiber signalling pathways.
Supplied as a sterile-filtered, lyophilized powder in a sealed glass vial. Reconstitution is performed by the researcher. A certificate of analysis confirming identity and purity is enclosed with every order.
This summary describes where the compound has appeared in published research. It is provided for scientific context only and is not a claim of efficacy.
Every batch, on record.
Each lot is independently characterised by HPLC and mass spectrometry, verifying identity and molecular mass. The most recent ARA-290 lot (2025090901) measured 99.188% main-peak purity. The certificate of analysis ships inside every order.
Request the current ARA-290 lot COA before you order, or browse the library.
View COA Library






